Citius Pharmaceuticals Inc (CTXR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.75
• Market Cap: $16.74M
• EPS: $-2.46
• 52-Week High: $2.48
• 52-Week Low: $0.63

Market Sentiment

Citius Pharmaceuticals Inc currently has a Neutral sentiment score of 0.11.

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals, Inc. (CTXR) is a biopharmaceutical company headquartered in Cranford, New Jersey, that specializes in developing and commercializing innovative products for critical care settings. With a focus on addressing significant unmet medical needs, Citius boasts a promising pipeline of therapies aimed at improving patient outcomes in hospitals. The company's commitment to advancing healthcare is bolstered by its utilization of cutting-edge technology and strategic partnerships...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Citius Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CTXR pay dividends?

Citius Pharmaceuticals Inc (CTXR) does not currently pay a regular dividend.

What is CTXR's market cap?

Citius Pharmaceuticals Inc (CTXR) has a market capitalization of $16.74M with a current stock price of $0.75.